4-Hydroxythiobenzamide-Products-Jinan Xinnuo Pharmaceutical Technology Co., Ltd.

Description

4-Hydroxythiobenzamide is used in the synthesis of PPARα agonists used in increasing HDLc levels. Also used in the synthesis of potent CDK5 inhibitors in the treatment of Alzheimer’s disease.

Basic Info

Chemical Name	4-[amino(sulfanyl)methylidene]cyclohexa-2,5-dien-1-one
Synonyms	4-(aminothioxomethyl)phenol;BENZENECARBOTHIOAMIDE,4-HYDROXY;p-hydroxybenzothiomide;4-HydroxythiobenzaMide;4-hydroxybenzothioamide;4-hydroxybenzenecarbothioamide; 4-Hydroxybenzene-1-carbothioamide;
CAS No.	25984-63-8
Molecular Formula	C7H7NOS
Molecular Weight	153.20200
PSA	78.34000
LogP	1.72670

Properties

Appearance & Physical State	Grey white powder
Density	1.339 g/cm3
Boiling Point	320.394ºC at 760 mmHg
Refractive Index	1.702
Vapor Pressure	0mmHg at 25°C

Safety Info

Safety Statements	S26; S36/37/39
HS Code	2930909090
Risk Statements	R20/21/22

Company Profile

Jinan Xinnuo Pharmaceutical Technology Co., Ltd. is a high-tech enterprise specializing in the production of pharmaceutical intermediates. The company has been engaged in the research, development and production of chemical intermediates for more than 10 years. It integrates research, development, production, import and export trade, strong technical force, advanced testing methods, strong research and development capabilities and superb synthetic technology. It is an incubator of Jinan Pharmaceutical Valley. Committed to gout, nutrition, anti-cancer, anti-depression, anti-age dementia and drug synthesis in the cardiovascular and cerebrovascular fields. The products are mainly exported, and the products are exported to more than 40 countries and regions such as Southeast Asia, South America and Eastern Europe.

The company has a complete quality assurance system and strong scientific research and innovation strength. Every year, new market-oriented and high-tech synthetic drugs are launched. We are willing to provide you with quality products and competitive prices. Efficient service.